Can mutations in gamma-actin modulate the toxicity of microtubule targeting agents?
Fojo
Tito
T
D000199:Actins / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D007930:Leucine; D008870:Microtubules / Q000187:drug effects* / Q000378:metabolism; D009154:Mutation / Q000187:drug effects*; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D011392:Proline; D034741:RNA, Small Interfering; D014404:Tubulin / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D050257:Tubulin Modulators / Q000494:pharmacology*; D014633:Valine; D014750:Vincristine / Q000494:pharmacology
D000199:Actins; D000970:Antineoplastic Agents; D034741:RNA, Small Interfering; D014404:Tubulin; D050257:Tubulin Modulators; D014750:Vincristine; D011392:Proline; D007930:Leucine; D014633:Valine